• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Decentralized Clinical Research Will Be A Paradigm-Shifting Trend

by Zeenia Framroze, Director of Strategy and Business Operations at Sharecare 11/12/2021 Leave a Comment

The future of clinical research has arrived

The field of clinical research is on the precipice of change, and for good reason. Traditional clinical trials and processes are primarily confined to sterile, isolated clinical settings that are often narrow in scope and provider-centric. Researchers of tomorrow, however, already are identifying accurate and effective new methods to conduct and draw meaning from their work, after concluding that current models for clinical research are not capturing participants’ real-world, lived experiences
Read More

Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment

by Fred Pennic 11/11/2021 Leave a Comment

What You Should Know: - Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes. - Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify and select volasertib-responsive patients prior to their treatment and fast-track volasertib’s clinical development
Read More

Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform

by Jasmine Pennic 11/11/2021 Leave a Comment

Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform

What You Should Know: - Nuritas, a biotech company that uses proprietary AI to discover plant-based actives (peptides) and make the products we consume healthier and more sustainable raises $45M in Series B funding led by Cleveland Avenue, LLC. The round also included participation from Cultivian Sandbox Ventures, VisVires New Protein, U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi. - Founded in 2014, Nuritas’ computational approach to discovery uses
Read More

3 Barriers to Decentralized Clinical Trials Adoption

by Michael Delisle, VP, Practice Leader for Digital Health at GattiHR 11/09/2021 Leave a Comment

3 Barriers to Decentralized Clinical Trials Adoption

It’s official. Decentralized clinical trials have disrupted the clinical trial process for good. The COVID-19 pandemic elevated many digital innovations, proving that virtually connecting with patients is not only convenient but necessary when it comes to providing equitable access to cutting-edge treatments and clinical research. Historically, traditional clinical trials have always experienced recruitment and retention challenges due to inconveniently located trial sites, lack of awareness
Read More

Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion

by Michael Delisle, VP, Practice Leader for Digital Health at GattiHR 11/03/2021 Leave a Comment

Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion

The U.S. pharma industry and research intuitions have long struggled with increasing clinical trial diversity in an effective, sustainable, and scalable fashion. Clinical research, in general, acknowledges the universal struggle of recruiting enough participants from various demographic groups. For example, racial and ethnic minorities have been historically underrepresented in clinical trials—a problem that still persists today. According to Deloitte, African Americans comprise 13% of the
Read More

Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform

by Fred Pennic 10/26/2021 Leave a Comment

Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform

What You Should Know: - Decentralized Clinical Trials (DCT) leader Medable, today announced a $304M Series D funding round today – the company’s largest and fourth funding round in 18 months, bringing total capital raised to $521M – and valuation to $2B+. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire
Read More

Cerner Enviza Launches to Accelerate Therapies and Improve Patient Outcomes

by Jasmine Pennic 10/26/2021 Leave a Comment

Cerner Enviza Launches to Accelerate Therapies and Improve Patient Outcomes

What You Should Know: - Today, Cerner announced the launch of Cerner Enviza, a new operating unit that offers solutions to help bring clarity to multi-dimensional data through real-world evidence and insights. - Cerner Enviza℠ aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of healthcare innovation, life sciences knowledge and collaborative research, Cerner
Read More

FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments

by Jasmine Pennic 10/21/2021 Leave a Comment

Syneos Health, Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization

What You Should Know: - Aetion, a NYC-based leading real-world evidence (RWE) company,  announced that the U.S. Food and Drug Administration (FDA) has contracted with them to use their Aetion Evidence Platform® to rapidly assess in-patient COVID-19 treatments and advance regulatory science to help determine when, where and how to use RWD. - This project is designed to demonstrate how using a platform-based approach
Read More

3 Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates

by Ryan Pack, Global Head Diversity in Clinical Trials, Science 37 10/20/2021 Leave a Comment

Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates

I consider myself living proof of the American dream. In 1888, my great, great grandfather purchased a farm, Coleman Crest, that is still in our family today. Understanding his story and what he had to overcome during that period in history has given me such a great foundation and what still inspires me today.  My passion for chemistry began when I was a child. At a young age, I was diagnosed with a chronic illness and when things got tough, it was my pharmacist who gave me hope and
Read More

3 Ways to Address Gender and Racial Bias in Clinical Trials

by Jennifer Jones-McMeans, PhD, Divisional Vice President of Global Clinical Affairs at Abbott’s Vascular Business 10/13/2021 Leave a Comment

Addressing Gender and Racial Bias in Clinical Trials, Racial Bias Clinical Trials, Gender and Racial Bias, Clinical Trials Racial Bias

I have dedicated my career to clinical research and making strides to advance modern medicine. In the work I do as a clinical researcher, we are addressing racial and gender biases that exist today in clinical trials. For example, in cardiovascular disease—my area of study—we know that women’s symptoms present differently than men and yet their symptoms have often gone undiagnosed or dismissed by physicians. It is well documented that communities of color have historically been mistreated by
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 63
  • Go to page 64
  • Go to page 65
  • Go to page 66
  • Go to page 67
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |